The clinical analysis of 156cases on the effects of mifepristone and gestrinone treatment for postoperative patients with severe pelvic endometriosis
Ke Hu
Abstract
Ke Hu
Abstract
Objective:To investigate the effects and safety of mifepristone and gestrinone for treating for postoperative patients with severe pelvic endometriosis.Methods:156 severe pelvic endometriosis cases were analyzed retrospectively . Of the cases , 59 cases were administered mifepristone , 45 cases were administered gestrinone and other 52 cases had not taken any hormone . Recurrence rate , side effect rate were compared among these groups.Results:The recurrence rate of mifepristone group and gestrinone group was 13.6% and 11.1% , respectively , which was significantly lower than that of control group(P0.05,P0.05).The side effect rate of mifepristone group was 11.9% , which was significantly lower than that of gestrinone group(44.4%)(P0.05).Conclusion:The treatment of mifepristone and gestrinone treatment on postoperative patients with pelvic endometriosis can significantly decreased the recurrence rate of pelvic endometriosis , and elevate pregnancy rate . Mifepristone has less side effects than that of gestrinone .
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective:To investigate the effects and safety of mifepristone and gestrinone for treating for postoperative patients with severe pelvic endometriosis.Methods:156 severe pelvic endometriosis cases were analyzed retrospectively . Of the cases , 59 cases were administered mifepristone , 45 cases were administered gestrinone and other 52 cases had not taken any hormone . Recurrence rate , side effect rate were compared among these groups.Results:The recurrence rate of mifepristone group and gestrinone group was 13.6% and 11.1% , respectively , which was significantly lower than that of control group(P0.05,P0.05).The side effect rate of mifepristone group was 11.9% , which was significantly lower than that of gestrinone group(44.4%)(P0.05).Conclusion:The treatment of mifepristone and gestrinone treatment on postoperative patients with pelvic endometriosis can significantly decreased the recurrence rate of pelvic endometriosis , and elevate pregnancy rate . Mifepristone has less side effects than that of gestrinone .
Key concepts: Mifepristone, Medicine, Endometriosis, Urology, Gynecology, Pregnancy, Surgery, Biology